Personalis Management
Management criteria checks 2/4
Personalis' CEO is Chris Hall, appointed in Dec 2022, has a tenure of 2.42 years. total yearly compensation is $1.54M, comprised of 38.2% salary and 61.8% bonuses, including company stock and options. directly owns 0.074% of the company’s shares, worth €291.24K. The average tenure of the management team and the board of directors is 3.7 years and 3 years respectively.
Key information
Chris Hall
Chief executive officer
US$1.5m
Total compensation
| CEO salary percentage | 38.25% |
| CEO tenure | 2.4yrs |
| CEO ownership | 0.07% |
| Management average tenure | 3.7yrs |
| Board average tenure | 3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | -US$84m |
| Dec 31 2024 | US$2m | US$588k | -US$81m |
| Sep 30 2024 | n/a | n/a | -US$91m |
| Jun 30 2024 | n/a | n/a | -US$81m |
| Mar 31 2024 | n/a | n/a | -US$93m |
| Dec 31 2023 | US$2m | US$534k | -US$108m |
| Sep 30 2023 | n/a | n/a | -US$113m |
| Jun 30 2023 | n/a | n/a | -US$110m |
| Mar 31 2023 | n/a | n/a | -US$114m |
| Dec 31 2022 | US$2m | US$83k | -US$113m |
Compensation vs Market: Chris's total compensation ($USD1.54M) is above average for companies of similar size in the German market ($USD917.60K).
Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.
CEO
Chris Hall (55 yo)
2.4yrs
Tenure
US$1,535,960
Compensation
Mr. Christopher M. Hall, also known as Chris, served as Senior Vice President and Head of Diagnostics Business at Personalis, Inc. since October 2022 until December 31, 2022 and serves as its President sin...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.4yrs | US$1.54m | 0.074% € 291.2k | |
| CFO & COO | 6.2yrs | US$1.01m | 0.18% € 722.1k | |
| Executive VP of R&D and Chief Medical Officer | 3.8yrs | US$989.39k | 0.14% € 531.1k | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Senior VP | 5.1yrs | US$674.28k | 0.075% € 292.5k | |
| Senior Vice President of Genomic Laboratory Operations | 3.7yrs | no data | no data | |
| Senior Vice President of Business Development | 2.3yrs | no data | no data | |
| Senior Vice President of Regulatory | 1.6yrs | no data | no data |
3.7yrs
Average Tenure
53yo
Average Age
Experienced Management: 04X's management team is considered experienced (3.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.2yrs | US$1.54m | 0.074% € 291.2k | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 1.9yrs | US$90.81k | 0% € 0 | |
| Independent Chair of the Board | 5.7yrs | US$165.81k | 0.015% € 60.0k | |
| Independent Director | 6yrs | US$110.81k | 0.015% € 60.0k | |
| Independent Director | 4.2yrs | US$98.31k | 0.030% € 116.0k | |
| Advisor to the Board | 2.4yrs | US$5.62m | no data | |
| Independent Director | 2.8yrs | US$93.31k | 0.023% € 91.6k | |
| Independent Director | 3.2yrs | US$110.49k | 0.024% € 93.3k |
3.0yrs
Average Tenure
67yo
Average Age
Experienced Board: 04X's board of directors are not considered experienced ( 3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/18 09:24 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Personalis, Inc. is covered by 14 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Derik de Bruin | BofA Global Research |
| Mark Massaro | BTIG |
| Patrick Donnelly | Citigroup Inc |